COLL
HEALTHCARECollegium Pharmaceutical Inc
$36.51+1.19 (+3.37%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving COLL Today?
No stock-specific AI insight has been generated for COLL yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$27.84$50.79
$36.51
Fundamentals
Market Cap$1.2B
P/E Ratio21.1
EPS$1.73
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume901K
Avg Volume (10D)—
Shares Outstanding32.4M
COLL News
20 articles- Collegium Pharmaceutical, Inc. Q1 2026 Earnings Call SummaryMoby·May 7, 2026
- Collegium (COLL) Q1 2026 Earnings TranscriptMotley Fool·May 7, 2026
- Collegium Pharmaceutical Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesYahoo Finance·May 7, 2026
- Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat EstimatesYahoo Finance·May 7, 2026
- Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 CY2026 Expectations, Stock SoarsYahoo Finance·May 7, 2026
- Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company ProgressYahoo Finance·May 7, 2026
- 1 Small-Cap Stock on Our Watchlist and 2 We QuestionYahoo Finance·May 5, 2026
- Earnings Preview: Collegium Pharmaceutical (COLL) Q1 Earnings Expected to DeclineYahoo Finance·Apr 30, 2026
- Collegium to Report First Quarter 2026 Financial Results on May 7, 2026Yahoo Finance·Apr 23, 2026
- Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham ConferenceMarketbeat·Apr 16, 2026
- 3 of Wall Street’s Favorite Stocks with Questionable FundamentalsYahoo Finance·Apr 14, 2026
- How The Collegium Pharmaceutical (COLL) Narrative Is Evolving On A Modest Target Price ShiftYahoo Finance·Apr 12, 2026
- 3 Cash-Producing Stocks Walking a Fine LineYahoo Finance·Apr 10, 2026
- Collegium to Participate in Upcoming Investor ConferencesYahoo Finance·Apr 8, 2026
- 1 Value Stock on Our Buy List and 2 Facing HeadwindsYahoo Finance·Apr 6, 2026
- GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To KnowYahoo Finance·Apr 3, 2026
- 2 Profitable Stocks to Consider Right Now and 1 We QuestionYahoo Finance·Apr 2, 2026
- Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug ManufacturersYahoo Finance·Mar 31, 2026
- Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHDThe Motley Fool·Mar 31, 2026
All 20 articles loaded
Price Data
Open$35.09
Previous Close$35.32
Day High$36.76
Day Low$35.09
52 Week High$50.79
52 Week Low$27.84
52-Week Range
$27.84$50.79
$36.51
Fundamentals
Market Cap$1.2B
P/E Ratio21.1
EPS$1.73
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume901K
Avg Volume (10D)—
Shares Outstanding32.4M
About Collegium Pharmaceutical Inc
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—